Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05405595
Title ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adagene Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute RECRUITING Scottsdale Arizona 85251 United States Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
Florida cancer specialist RECRUITING Sarasota Florida 34232 United States Details
Dong -A University Hospital RECRUITING Seogu Busan Gwangyeogsi 49201 Korea, Republic of Details
Chungbuk National University Hospital RECRUITING Cheongju-si Chungcheongbugdo 28644 Korea, Republic of Details
CHA Bundang Medical Center, CHA university RECRUITING Seongnam Gyeonggido 13496 Korea, Republic of Details
The Catholic University of Korea Street. Vincent Hospital RECRUITING Suwon Gyeonggido 16247 Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul Seoul Teugbyeolsi 06351 Korea, Republic of Details
Keimyung University Dongsan Hospital RECRUITING Daegu 41931 Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul 03080 Korea, Republic of Details
KangBuk Samsung Hospital RECRUITING Seoul 03081 Korea, Republic of Details
Asan Medical Center RECRUITING Seoul 05505 Korea, Republic of Details
Severance Hospital Yonsei University Health System RECRUITING Seoul 3722 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field